Skip to main content
Livermore
Livermore
ZHEN

Fred Alger Management, LLC

SEC CIK
0000003520
Latest filing
Aug 14, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Fred Alger Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
648,611
Value
$16.4M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ACAD by Fred Alger Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026648,611$16.4M0.1%−628,540−49.2%ReducedHolders
Q1 20261,277,151$28.4M0.1%−282,811−18.1%ReducedHolders
Q4 20251,559,962$41.7M0.2%−7,073−0.5%ReducedHolders
Q3 20251,567,035$33.4M0.1%−820,421−34.4%ReducedHolders
Q2 20252,387,456$51.5M0.2%−382,372−13.8%ReducedHolders
Q1 20252,769,828$46.0M0.3%+54,899+2.0%AddedHolders
Q4 20242,714,929$49.8M0.2%−471,460−14.8%ReducedHolders
Q3 20243,186,389$49.0M0.2%+481,950+17.8%AddedHolders
Q2 20242,704,439$43.9M0.2%+446,875+19.8%AddedHolders
Q1 20242,257,564$41.7M0.2%−919,211−28.9%ReducedHolders
Q4 20233,176,775$99.5M0.5%+67,892+2.2%AddedHolders
Q3 20233,108,883$64.8M0.4%+867,818+38.7%AddedHolders
Q2 20232,241,065$53.7M0.3%+515,439+29.9%AddedHolders
Q1 20231,725,626$32.5M0.2%+262,972+18.0%AddedHolders
Q4 20221,462,654$23.3M0.1%−74,180−4.8%ReducedHolders
Q3 20221,536,834$25.1M0.1%−84,934−5.2%ReducedHolders
Q2 20221,621,768$22.9M0.1%−94,169−5.5%ReducedHolders
Q1 20221,715,937$41.6M0.1%−123,916−6.7%ReducedHolders
Q4 20211,839,853$42.9M0.1%−333,105−15.3%ReducedHolders
Q3 20212,172,958$36.1M0.1%−630,409−22.5%ReducedHolders
Q2 20212,803,367$68.4M0.2%+17,105+0.6%AddedHolders
Q1 20212,786,262$71.9M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.